Phytoestrogen genistein as an anti-staphylococcal agent

Margareta Verdrengh1, L Vincent Collins, Philip Bergin

  • 1Department of Rheumatology and Inflammation Research, University of Göteborg, Guldhedsgatan 10A, 413 46, Gothenburg, Sweden. margareta.verdrengh@rheuma.gu.se

Microbes and Infection
|January 24, 2004
PubMed

Insights

Genistein, a soy isoflavone, shows strong antibacterial effects against various bacteria, including resistant strains. Its mechanism may involve inhibiting topoisomerase II, offering potential for new antibacterial therapies.

Area of Science:

  • Biochemistry
  • Microbiology
  • Pharmacology

Background:

  • Genistein, a soybean isoflavone, has known effects on mammalian cells via topoisomerase II and protein tyrosine kinase inhibition.
  • Its potential antibacterial properties remain largely unexplored.

Purpose of the Study:

  • To investigate the in vitro antibacterial activity of genistein against various bacterial strains.
  • To explore the potential mechanism of genistein's antibacterial action.

Main Methods:

  • Bacterial strains were incubated with varying concentrations of genistein for different durations.
  • Viable bacterial counts were assessed to determine growth inhibition.
  • Daidzein, a related compound, was used for comparative analysis.

Main Results:

  • Genistein inhibited the growth of all tested staphylococcal strains, including methicillin-resistant Staphylococcus aureus (MRSA).
  • Significant growth inhibition was observed for Streptococcus pasteurianus, Bacillus cereus, and Helicobacter pylori.
  • Escherichia coli growth was not suppressed by genistein.
  • Daidzein showed weaker inhibition of Staphylococcus aureus compared to genistein.

Conclusions:

  • Genistein possesses potent in vitro antibacterial properties.
  • The antibacterial activity may be linked to the inhibition of topoisomerase II, potentially by stabilizing the enzyme-DNA complex.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...